SynthesisBMC psychiatry2025
Prevalence of and risk factors for suicidal ideation among perinatal women with HIV infection: a systematic review, meta-analysis, and meta-regression.
Synthesis in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe prevalence of suicidal ideation (SI) among HIV-positive pregnant women is a complex issue influenced by multiple risk factors. By addressing these risk factors and focusing on vulnerable regions, healthcare providers and policymakers can strive to alleviate the burden of SI in this population. The objective of this systematic review, meta-analysis, and meta-regression was to estimate the prevalence and identify risk factors for SI among HIV-positive pregnant women.
methodsThe review systematically searched PubMed, Scopus and Web of Science to identify relevant studies published until December 2024. A meta-analysis was conducted to summarize the prevalence and risk factors for SI among pregnant women with HIV infection. Sensitivity and meta-regression analysis were performed to explore the potential sources of heterogeneity in the distribution and determinants of suicidal behaviors within this at-risk group.
resultsThe review identified 18 studies involving 5,242 participants. The overall prevalence of SI was 20.5%; 95% CI: 14.6 - 28.0% in pregnant women living with HIV, 19.8%; 95% CI: 12.6 - 29.6% in perinatal, and 14.9%; 95% CI: 7.8 - 26.5% in prenatal. The prevalence of SI was 17.1%, 20.3%, and 34.5% for the periods 2020-2024, 2015-2019, and 2000-2014, respectively. By gross domestic product (GDP), the prevalence was 16.9% in low, 23.0% in moderate, and 24.1% in high GDP countries, with the highest prevalence in the USA (24.2%). Among various risk factors, partner violence (OR = 1.44; 95% CI: 1.05-1.98), and higher education (OR = 0.80; 95% CI: 0.64-0.99) were identified as significant risk factors and protective factors, respectively. Meta-regression analysis indicated that GDP, partner violence, year, age, and depression were potential sources of heterogeneity, respectively.
conclusionThe results indicated a high prevalence of SI among perinatal women living with HIV. The educational level, GDP, partner violence, and year were significant risk factors and potential sources of heterogeneity. It is crucial to incorporate specific questions about suicidal ideation into routine prenatal care for this population, even when depressive symptoms are not apparent. These findings underscore the need for a multifaceted approach to addressing suicidal ideation in HIV-positive prenatal women.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.